Inpare ApS is a Danish APS based in Hørsholm, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2015, the company reported a gross profit of -DKK 218.8k in its latest annual filing.
| Gross profit | -218.8K DKK | +85% |
| EBITDA | -261.9K DKK | -121% |
| Net profit | -272.8K DKK | -91% |
| Total assets | 81.3K DKK | +1040% |
| Equity | -735.5K DKK | -59% |
| Employees | — | — |
In its most recent annual report (2023), Inpare ApS reported a gross profit of -DKK 218.8k. The figures on this page draw on 5 annual filings covering 2019 to 2023. The bottom line showed a net loss of DKK 272.8k.
At the end of 2023, current assets covered short-term debt 0.1 times.
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Gross profit | -219 | -118 | -98 | -197 | -100 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -262 | -118 | -98 | -197 | -100 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -262 | -118 | -98 | -197 | -100 |
| Net financials | -20 | -0 | -0 | 0 | 0 |
| Profit before tax | -282 | -119 | -98 | -197 | -100 |
| Tax | -9 | 24 | -22 | -64 | -22 |
| Net profit | -273 | -143 | -77 | -133 | -78 |
| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total assets | 81 | 7 | 89 | 119 | 36 |
| Equity | -736 | -463 | -320 | -243 | -110 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 817 | 470 | 409 | 362 | 147 |
| Total debt | 817 | 470 | 409 | 362 | 147 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
Net profit as a percentage of total assets — the return generated on the capital employed.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|
CJ Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
OP Management | Management | 2015 – 2023 |
PD Chief Executive Officer | Chief Executive Officer | 2015 – 2018 |
PH Management | Management | 2015 – 2023 |
SA Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
| Name | Role | Member since |
|---|
OP Board of Directors | Board of Directors | 2018 – 2023 |
PD Board of Directors | Board of Directors | 2015 – 2018 |
PH Chairman | Chairman | 2015 – 2023 |
| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Individual | 20–24.99% | 20–24.99% | 2016 | |
| Individual | 100% | 100% | 2015 | |
| Company | 66.67–89.99% | 66.67–89.99% | 2018 | |
| Individual | 100% | 100% | 2023 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2016 |
| Person | Role here | Other companies |
|---|---|---|
| Claus Juan Møller-San Pedro | Chief Executive Officer | 6 companiesMany roles |
| Per Holm | Management | 6 companiesMany roles |
| Peter David Gruhn | Chief Executive Officer | 4 companies |
| Søren Anker Nielsen | Chief Executive Officer | 3 companies |